Lanuginosine
Product Specifications
UNSPSC Description
Lanuginosine (Compound 12) is an AChE inhibitor (IC50: 10.9 μM). Lanuginosine inhibits Aβ aggregation. Lanuginosine can be used for research of Alzheimer’s disease[1].
Target Antigen
Amyloid-β; Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/lanuginosine.html
Purity
98.27
Solubility
DMSO : 0.5 mg/mL (ultrasonic;warming;adjust pH to 2 with 1 M HCL;heat to 60°C)
Smiles
O=C1C2=CC(OC)=CC=C2C3=C4OCOC4=CC5=CC=NC1=C53
Molecular Weight
305.28
References & Citations
[1]Jiang K, et al. Bioactive Isoquinoline Alkaloids with Diverse Skeletons from Fissistigma polyanthum. J Nat Prod. 2023 Aug 24.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-119398/Lanuginosine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-119398/Lanuginosine-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
23740-25-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
